| |
| |
|
| Insider
Information: |
Junius Daniel M |
| Relationship: |
|
| City: |
Groton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
286,488 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,457,487 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
286,488 |
|
|
| Total
Value |
$7,457,487 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
7
|
|
Stock
price went up :
|
2
|
4
|
| Stock
price went down : |
1
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
1.3
|
| Percentage
Gain/Loss : |
 21.7%
|
95.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunogen Inc |
IMGN |
Director |
2018-03-16 |
184,987 |
2007-08-15 |
0 |
Premium* |
|
|
Idexx Laboratories Inc |
IDXX |
Director |
2024-01-30 |
3,042 |
|
0 |
Premium* |
|
|
Glycomimetics Inc |
GLYC |
|
2024-03-29 |
98,459 |
2016-12-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GLYC |
Glycomimetics Inc |
|
– • – |
2024-03-29 |
4 |
A |
$3.00 |
$15,627 |
D/D |
5,209 |
98,459 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2024-01-30 |
4 |
A |
$521.03 |
$7,294 |
D/D |
14 |
3,042 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2023-10-30 |
4 |
A |
$396.39 |
$7,531 |
D/D |
19 |
3,028 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2023-07-28 |
4 |
A |
$552.78 |
$7,739 |
D/D |
14 |
3,009 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2023-05-10 |
4 |
B |
$1.56 |
$46,800 |
D/D |
30,000 |
93,250 |
2.39 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2023-04-28 |
4 |
A |
$492.16 |
$6,398 |
D/D |
13 |
2,995 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2023-02-16 |
4 |
S |
$511.68 |
$1,119,044 |
D/D |
(2,187) |
2,982 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2023-02-16 |
4 |
OE |
$206.62 |
$451,878 |
D/D |
2,187 |
5,169 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2023-01-30 |
4 |
A |
$482.95 |
$6,761 |
D/D |
14 |
2,982 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-12-05 |
4 |
S |
$424.91 |
$1,294,276 |
D/D |
(3,046) |
2,968 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-12-05 |
4 |
OE |
$160.28 |
$488,213 |
D/D |
3,046 |
6,014 |
0 |
- |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2022-11-17 |
4 |
B |
$1.87 |
$37,400 |
D/D |
20,000 |
63,250 |
2.39 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-10-28 |
4 |
A |
$364.28 |
$6,557 |
D/D |
18 |
2,968 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-07-29 |
4 |
A |
$399.18 |
$6,387 |
D/D |
16 |
2,950 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-04-29 |
4 |
A |
$430.48 |
$6,457 |
D/D |
15 |
2,934 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2022-01-28 |
4 |
A |
$489.05 |
$6,358 |
D/D |
13 |
2,919 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-10-29 |
4 |
A |
$666.14 |
$6,661 |
D/D |
10 |
2,906 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-08-10 |
4 |
S |
$679.58 |
$1,632,355 |
D/D |
(2,402) |
2,896 |
0 |
% |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-08-10 |
4 |
OE |
$85.00 |
$204,170 |
D/D |
2,402 |
5,298 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-07-30 |
4 |
A |
$678.53 |
$6,785 |
D/D |
10 |
2,896 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-05-21 |
4 |
OE |
$85.00 |
$212,500 |
D/D |
2,500 |
5,386 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-05-21 |
4 |
S |
$539.57 |
$1,348,918 |
D/D |
(2,500) |
2,886 |
0 |
% |
|
| GLYC |
Glycomimetics Inc |
Director |
– • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
5,250 |
43,250 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-04-30 |
4 |
A |
$548.99 |
$6,039 |
D/D |
11 |
2,886 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Director |
– • – |
2021-02-22 |
4 |
S |
$538.57 |
$1,022,207 |
D/D |
(1,898) |
2,875 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
